TELADOC HEALTH ($TDOC) posted quarterly earnings results on Tuesday, July 29th. The company reported earnings of -$0.19 per share, beating estimates of -$0.27 by $0.08. The company also reported revenue of $631,900,000, missing estimates of $635,524,086 by $-3,624,086.
You can see Quiver Quantitative's $TDOC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TELADOC HEALTH Insider Trading Activity
TELADOC HEALTH insiders have traded $TDOC stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $TDOC stock by insiders over the last 6 months:
- MALA MURTHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 41,936 shares for an estimated $319,480.
- ADAM C VANDERVOORT (CHIEF LEGAL OFFICER, SECRETARY) has made 0 purchases and 2 sales selling 16,819 shares for an estimated $132,599.
- FERNANDO M. RODRIGUES (President of BetterHelp) has made 0 purchases and 5 sales selling 14,256 shares for an estimated $111,717.
- KELLY BLISS (President, U.S. Group Health) has made 0 purchases and 2 sales selling 14,123 shares for an estimated $111,694.
- CARLOS NUENO (President, International) has made 0 purchases and 2 sales selling 12,224 shares for an estimated $96,784.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TELADOC HEALTH Hedge Fund Activity
We have seen 160 institutional investors add shares of TELADOC HEALTH stock to their portfolio, and 185 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 4,669,961 shares (-41.8%) from their portfolio in Q1 2025, for an estimated $37,172,889
- GOLDMAN SACHS GROUP INC removed 3,740,751 shares (-56.7%) from their portfolio in Q1 2025, for an estimated $29,776,377
- BLACKROCK, INC. removed 2,151,254 shares (-12.6%) from their portfolio in Q1 2025, for an estimated $17,123,981
- DIMENSIONAL FUND ADVISORS LP added 1,519,618 shares (+43.0%) to their portfolio in Q1 2025, for an estimated $12,096,159
- BANK OF AMERICA CORP /DE/ added 1,375,308 shares (+213.5%) to their portfolio in Q1 2025, for an estimated $10,947,451
- VANGUARD GROUP INC added 1,289,183 shares (+7.0%) to their portfolio in Q1 2025, for an estimated $10,261,896
- BARCLAYS PLC removed 1,171,990 shares (-72.4%) from their portfolio in Q1 2025, for an estimated $9,329,040
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TELADOC HEALTH Analyst Ratings
Wall Street analysts have issued reports on $TDOC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 05/01/2025
- Goldman Sachs issued a "Buy" rating on 05/01/2025
- Piper Sandler issued a "Overweight" rating on 02/27/2025
To track analyst ratings and price targets for TELADOC HEALTH, check out Quiver Quantitative's $TDOC forecast page.
TELADOC HEALTH Price Targets
Multiple analysts have issued price targets for $TDOC recently. We have seen 11 analysts offer price targets for $TDOC in the last 6 months, with a median target of $8.75.
Here are some recent targets:
- Steven Valiquette from Mizuho set a target price of $10.0 on 07/25/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $8.0 on 07/09/2025
- Allen Lutz from B of A Securities set a target price of $7.0 on 05/28/2025
- Jailendra Singh from Truist Securities set a target price of $9.0 on 05/27/2025
- Stan Berenshteyn from Wells Fargo set a target price of $8.0 on 05/08/2025
- Richard Close from Canaccord Genuity set a target price of $12.0 on 05/01/2025
- David Roman from Goldman Sachs set a target price of $10.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
